# Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo

> **NCT07283562** · NA · COMPLETED · sponsor: **The First Hospital of Hebei Medical University** · enrollment: 100 (actual)

## Conditions studied

- Sensorineural Hearing Loss
- Vertigo

## Interventions

- **DRUG:** Gastrodin Injection
- **DRUG:** Conventional Therapy

## Key facts

- **NCT ID:** NCT07283562
- **Lead sponsor:** The First Hospital of Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-01
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283562, "Gastrodin Acupoint Injection for Sensorineural Hearing Loss With Vertigo". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07283562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*